Sold as Tegopen. Every FDA application for this active ingredient: 1 branded and 7 generic.
As of Nov 16, 2026, FDA lists 8 applications for Cloxacillin Sodium (sold as Tegopen), with 0 new uses approved and 0 published complete response letters.
| Antibiotic Tissue Penetration and Tissue Response in Head and Neck Infection and Reconstructive SurgerySurgical Wound Infection, Neck Infection · Tejs Ehlers Klug | Phase 4 | Recruiting | Oct 26, 2026 |
| Continuous Antibiotic Infusion In ChildrenInfection · Tampere University Hospital | Phase 3 | Recruiting | May 8, 2026 |
| Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus BacteremiaBacteriemia, Methicillin Susceptible Staphylococcus Aureus (MSSA) Infection · Central Hospital, Nancy, France | — | Active, not recruiting | Sep 22, 2025 |
| Unbound Cloxacillin Concentrations During Continuous InfusionStaphylococcal Infections · Emeli Månsson | Phase 4 | Recruiting | Feb 27, 2025 |
| Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus BacteraemiaStaphylococcus Aureus Bacteraemia, Staphylococcal Bacteraemia · Region Skane | Phase 4 | Recruiting | Dec 10, 2024 |
| Aminoglycosides in Early SepsisSepsis · University Hospital, Akershus | Phase 4 | Recruiting | Dec 2, 2024 |
| Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus BacteraemiaStaphylococcus Aureus Bacteremia · Hospital Universitari de Bellvitge | — | Active, not recruiting | Nov 19, 2024 |
| Stem Cell Treatment for Regeneration of the Rotator Cuff (Lipo-Cuff Study)Rotator Cuff Tears, Rotator Cuff Injuries · University of Southern Denmark | Phase 1 | Enrolling by invitation | Jul 17, 2024 |
| Apr 1, 1971 | Cloxacillin SodiumANDA 61452 | Apothecon | 0 | Discontinued |
| Sep 17, 1974 | CloxapenANDA 61806 | Glaxosmithkline | 0 | Discontinued |
| Jun 5, 1980 | Cloxacillin SodiumANDA 62240 | Chartwell Rx | 5 | Discontinued |
| Sep 15, 1980 | Cloxacillin SodiumANDA 62268 | Chartwell Rx | 7 | Discontinued |
| — | TegopenANDA 61453 | Apothecon | 0 | Discontinued |
| — | CloxapenANDA 62233 | Glaxosmithkline | 0 | Discontinued |
| — | Cloxacillin SodiumANDA 62978 | Chartwell Rx | 0 | Discontinued |
| — | TegopenNDA 50192 | Apothecon | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA